Table 2.
Baseline values (trest) of body composition on the four trial-related visits.
| Mean ± SD | 95% CI | p-Value | ||
|---|---|---|---|---|
| TBW (L) | CON | 41.3 ± 8.9 | 36.9–45.8 | >0.99 |
| ISO | 41.6 ± 9.0 | 36.9–46.2 | >0.99 | |
| GLU | 41.3 ± 9.1 | 36.7–45.8 | >0.99 | |
| RIN | 42.1 ± 2.8 | 37.3–47.0 | >0.99 | |
| ICW (L) | CON | 26.0 ± 5.6 | 23.2–28.8 | >0.99 |
| ISO | 26.1 ± 5.6 | 23.2–29.0 | >0.99 | |
| GLU | 26.5 ± 5.7 | 23.4–29.5 | >0.99 | |
| RIN | 25.9 ± 5.7 | 23.1–28.8 | >0.99 | |
| ECW (L) | CON | 15.4 ± 3.3 | 13.7–17.0 | >0.99 |
| ISO | 15.4 ± 3.4 | 13.7–17.2 | >0.99 | |
| GLU | 15.7 ± 3.4 | 13.8–17.5 | >0.99 | |
| RIN | 15.4 ± 3.4 | 13.7–17.0 | >0.99 | |
| SMM (kg) | CON | 31.9 ± 7.3 | 28.3–35.5 | >0.99 |
| ISO | 32.1 ± 7.3 | 28.3–25.9 | >0.99 | |
| GLU | 32.6 ± 7.5 | 28.6–36.5 | >0.99 | |
| RIN | 31.8 ± 7.5 | 28.1–35.5 | >0.99 | |
| FM (kg) | CON | 13.0 ± 3.9 | 11.0–14.9 | >0.99 |
| ISO | 14.7 ± 6.1 | 11.5–17.8 | >0.99 | |
| GLU | 12.6 ± 3.7 | 10.7–14.6 | >0.99 | |
| RIN | 13.3 ± 3.6 | 11.5–15.1 | >0.99 | |
| FM (%) | CON | 19.0 ± 5.4 | 16.3–21.7 | >0.99 |
| ISO | 19.4 ± 5.1 | 16.8–22.0 | >0.99 | |
| GLU | 18.3 ± 5.3 | 15.5–21.2 | >0.99 | |
| RIN | 19.4 ± 5.3 | 16.8–22.1 | >0.99 | |
| VFA (cm2) | CON | 51.3 ± 19.9 | 41.4–61.2 | >0.99 |
| ISO | 52.8 ± 18.3 | 43.4–62.2 | >0.99 | |
| GLU | 49.7 ± 19.2 | 39.4–59.9 | >0.99 | |
| RIN | 52.6 ± 18.4 | 43.5–61.8 | >0.99 |
SD = standard deviation, CI = confidence interval, TBW = total body water, ICW = intracellular water, ECW = extracellular water, SMM = skeletal muscle mass, FM = fat mass, VFA = visceral fat area.